Product References
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.
Molecular therapy oncolytics
Xia B,Lin K,Wang X,Chen F,Zhou M,Li Y,Lin Y,Qiao Y,Li R,Zhang W,He X,Zou F,Li L,Lu L,Chen C,Li W,Zhang H,Liu B
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Thu Sep 21 00:00:00 EDT 2023
PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses.
eLife
Anderson W,Barahmand-Pour-Whitman F,Linsley PS,Cerosaletti K,Buckner JH,Rawlings DJ
25-7029-42 was used in Flow cytometry/Cell sorting to suggest that, in primary human T cells, PTPN22 rs2476601 contributes to autoimmunity risk by permitting increased TCR signaling and activation in mildly self-reactive T cells, thereby potentially expanding the self-reactive T cell pool and skewing this population toward an inflammatory phenotype.
Fri Mar 24 00:00:00 EDT 2023
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents.
Nature communications
Koerber N,Priller A,Yazici S,Bauer T,Cheng CC,Mijočević H,Wintersteller H,Jeske S,Vogel E,Feuerherd M,Tinnefeld K,Winter C,Ruland J,Gerhard M,Haller B,Christa C,Zelger O,Roggendorf H,Halle M,Erber J,Lingor P,Keppler O,Zehn D,Protzer U,Knolle PA
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Mon Jan 10 00:00:00 EST 2022
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
Cell reports. Medicine
Jeong HW,Kim SM,Jung MK,Noh JY,Yoo JS,Kim EH,Kim YI,Yu K,Jang SG,Gil J,Casel MA,Rare R,Choi JH,Kim HS,Kim JH,Um J,Kim C,Kim Y,Chin BS,Jung S,Choi JY,Song KH,Kim YD,Park JS,Song JY,Shin EC,Choi YK
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Tue Oct 18 00:00:00 EDT 2022
CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells.
Journal of immunology (Baltimore, Md. : 1950)
Christian ML,Dapp MJ,Scharffenberger SC,Jones H,Song C,Frenkel LM,Krumm A,Mullins JI,Rawlings DJ
25-7029-42 was used in Flow cytometry/Cell sorting to model the effects of HIV integration within BACH2 Integration of the HIV long terminal repeat (LTR) and major splice donor increased BACH2 mRNA and protein levels, altered gene expression, and promoted selective outgrowth of an activated, proliferative, and T regulatory-like cell population.
Fri Apr 01 00:00:00 EDT 2022
Decreased Frequencies of Gamma/Delta T Cells Expressing Th1/Th17 Cytokine, Cytotoxic, and Immune Markers in Latent Tuberculosis-Diabetes/Pre-Diabetes Comorbidity.
Frontiers in cellular and infection microbiology
Kathamuthu GR,Kumar NP,Moideen K,Menon PA,Babu S
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Thu Nov 25 00:00:00 EST 2021
Platelets stimulate programmed death-ligand 1 expression by cancer cells: Inhibition by anti-platelet drugs.
Journal of thrombosis and haemostasis : JTH
Asgari A,Lesyk G,Poitras E,Govindasamy N,Terry K,To R,Back V,Rudzinski JK,Lewis JD,Jurasz P
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Mon Nov 01 00:00:00 EDT 2021
NKD2 mediates stimulation-dependent ORAI1 trafficking to augment Ca2+ entry in T cells.
Cell reports
Wu B,Woo JS,Vila P,Jew M,Leung J,Sun Z,Srikanth S,Gwack Y
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Tue Aug 24 00:00:00 EDT 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Nature communications
Alrubayyi A,Gea-Mallorquí E,Touizer E,Hameiri-Bowen D,Kopycinski J,Charlton B,Fisher-Pearson N,Muir L,Rosa A,Roustan C,Earl C,Cherepanov P,Pellegrino P,Waters L,Burns F,Kinloch S,Dong T,Dorrell L,Rowland-Jones S,McCoy LE,Peppa D
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Tue Oct 05 00:00:00 EDT 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.
Nature
Vogel AB,Kanevsky I,Che Y,Swanson KA,Muik A,Vormehr M,Kranz LM,Walzer KC,Hein S,Güler A,Loschko J,Maddur MS,Ota-Setlik A,Tompkins K,Cole J,Lui BG,Ziegenhals T,Plaschke A,Eisel D,Dany SC,Fesser S,Erbar S,Bates F,Schneider D,Jesionek B,Sänger B,Wallisch AK,Feuchter Y,Junginger H,Krumm SA,Heinen AP,Adams-Quack P,Schlereth J,Schille S,Kröner C,de la Caridad Güimil Garcia R,Hiller T,Fischer L,Sellers RS,Choudhary S,Gonzalez O,Vascotto F,Gutman MR,Fontenot JA,Hall-Ursone S,Brasky K,Griffor MC,Han S,Su AAH,Lees JA,Nedoma NL,Mashalidis EH,Sahasrabudhe PV,Tan CY,Pavliakova D,Singh G,Fontes-Garfias C,Pride M,Scully IL,Ciolino T,Obregon J,Gazi M,Carrion R,Alfson KJ,Kalina WV,Kaushal D,Shi PY,Klamp T,Rosenbaum C,Kuhn AN,Türeci Ö,Dormitzer PR,Jansen KU,Sahin U
25-7029-42 was used in flow cytometry to report the preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derived from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles.
Thu Apr 01 00:00:00 EDT 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.
Nature
Vogel AB,Kanevsky I,Che Y,Swanson KA,Muik A,Vormehr M,Kranz LM,Walzer KC,Hein S,Güler A,Loschko J,Maddur MS,Ota-Setlik A,Tompkins K,Cole J,Lui BG,Ziegenhals T,Plaschke A,Eisel D,Dany SC,Fesser S,Erbar S,Bates F,Schneider D,Jesionek B,Sänger B,Wallisch AK,Feuchter Y,Junginger H,Krumm SA,Heinen AP,Adams-Quack P,Schlereth J,Schille S,Kröner C,de la Caridad Güimil Garcia R,Hiller T,Fischer L,Sellers RS,Choudhary S,Gonzalez O,Vascotto F,Gutman MR,Fontenot JA,Hall-Ursone S,Brasky K,Griffor MC,Han S,Su AAH,Lees JA,Nedoma NL,Mashalidis EH,Sahasrabudhe PV,Tan CY,Pavliakova D,Singh G,Fontes-Garfias C,Pride M,Scully IL,Ciolino T,Obregon J,Gazi M,Carrion R,Alfson KJ,Kalina WV,Kaushal D,Shi PY,Klamp T,Rosenbaum C,Kuhn AN,Türeci Ö,Dormitzer PR,Jansen KU,Sahin U
25-7029-42 was used in flow cytometry to report the preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derived from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles.
Thu Apr 01 00:00:00 EDT 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.
Nature
Vogel AB,Kanevsky I,Che Y,Swanson KA,Muik A,Vormehr M,Kranz LM,Walzer KC,Hein S,Güler A,Loschko J,Maddur MS,Ota-Setlik A,Tompkins K,Cole J,Lui BG,Ziegenhals T,Plaschke A,Eisel D,Dany SC,Fesser S,Erbar S,Bates F,Schneider D,Jesionek B,Sänger B,Wallisch AK,Feuchter Y,Junginger H,Krumm SA,Heinen AP,Adams-Quack P,Schlereth J,Schille S,Kröner C,de la Caridad Güimil Garcia R,Hiller T,Fischer L,Sellers RS,Choudhary S,Gonzalez O,Vascotto F,Gutman MR,Fontenot JA,Hall-Ursone S,Brasky K,Griffor MC,Han S,Su AAH,Lees JA,Nedoma NL,Mashalidis EH,Sahasrabudhe PV,Tan CY,Pavliakova D,Singh G,Fontes-Garfias C,Pride M,Scully IL,Ciolino T,Obregon J,Gazi M,Carrion R,Alfson KJ,Kalina WV,Kaushal D,Shi PY,Klamp T,Rosenbaum C,Kuhn AN,Türeci Ö,Dormitzer PR,Jansen KU,Sahin U
25-7029-42 was used in flow cytometry to report the preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derived from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles.
Thu Apr 01 00:00:00 EDT 2021
Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand.
Cancer research communications
Ando M,Kondo T,Tomisato W,Ito M,Shichino S,Srirat T,Mise-Omata S,Nakagawara K,Yoshimura A
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Fri Oct 01 00:00:00 EDT 2021
Senolytic CAR T cells reverse senescence-associated pathologies.
Nature
Amor C,Feucht J,Leibold J,Ho YJ,Zhu C,Alonso-Curbelo D,Mansilla-Soto J,Boyer JA,Li X,Giavridis T,Kulick A,Houlihan S,Peerschke E,Friedman SL,Ponomarev V,Piersigilli A,Sadelain M,Lowe SW
25-7029 was used in Flow cytometry/Cell sorting to establish the therapeutic potential of senolytic CAR T cells for senescence-associated diseases.
Wed Jul 01 00:00:00 EDT 2020
CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
JCI insight
Imura Y,Ando M,Kondo T,Ito M,Yoshimura A
25-7029 was used in Flow cytometry/Cell sorting to suggest that CD19-CAR regulatory T cells can treat autoantibody-mediated autoimmune diseases by suppressing B cell pathology.
Thu Jul 23 00:00:00 EDT 2020
CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity.
Molecular therapy. Methods & clinical development
Preece R,Pavesi A,Gkazi SA,Stegmann KA,Georgiadis C,Tan ZM,Aw JYJ,Maini MK,Bertoletti A,Qasim W
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Fri Dec 11 00:00:00 EST 2020
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.
Nature communications
Webber BR,Lonetree CL,Kluesner MG,Johnson MJ,Pomeroy EJ,Diers MD,Lahr WS,Draper GM,Slipek NJ,Smeester BA,Lovendahl KN,McElroy AN,Gordon WR,Osborn MJ,Moriarity BS
25-7029-42 was used in Flow Cytometry to demonstrate that base editors can mediate highly efficient multiplex gene disruption with minimal double-strand break induction.
Tue Nov 19 00:00:00 EST 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.
Nature communications
Webber BR,Lonetree CL,Kluesner MG,Johnson MJ,Pomeroy EJ,Diers MD,Lahr WS,Draper GM,Slipek NJ,Smeester BA,Lovendahl KN,McElroy AN,Gordon WR,Osborn MJ,Moriarity BS
25-7029-42 was used in Flow Cytometry to demonstrate that base editors can mediate highly efficient multiplex gene disruption with minimal double-strand break induction.
Tue Nov 19 00:00:00 EST 2019
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
Cells
Coufal S,Galanova N,Bajer L,Gajdarova Z,Schierova D,Jiraskova Zakostelska Z,Kostovcikova K,Jackova Z,Stehlikova Z,Drastich P,Tlaskalova-Hogenova H,Kverka M
25-7029-42 was used in Flow Cytometry to prove the importance of the gut barrier function and immune response to commensal bacteria and point at the specific differences in pathogenesis of PSC-IBD, UC and CD.
Sat Jul 13 00:00:00 EDT 2019
Rab6-dependent retrograde traffic of LAT controls immune synapse formation and T cell activation.
The Journal of experimental medicine
Carpier JM,Zucchetti AE,Bataille L,Dogniaux S,Shafaq-Zadah M,Bardin S,Lucchino M,Maurin M,Joannas LD,Magalhaes JG,Johannes L,Galli T,Goud B,Hivroz C
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Mon Apr 02 00:00:00 EDT 2018
A novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignancies.
Protein engineering, design & selection : PEDS
De Luca R,Kachel P,Kropivsek K,Snijder B,Manz MG,Neri D
Published figure using IL-2 monoclonal antibody (Product # 25-7029-42) in Flow Cytometry
Tue May 01 00:00:00 EDT 2018
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.
PLoS pathogens
Lindestam Arlehamn CS,McKinney DM,Carpenter C,Paul S,Rozot V,Makgotlho E,Gregg Y,van Rooyen M,Ernst JD,Hatherill M,Hanekom WA,Peters B,Scriba TJ,Sette A
25-7029 was used in Flow cytometry/Cell sorting to estimate the breadth of T cell responses for the first time in the context of an infection and human population setting.
Fri Jul 01 00:00:00 EDT 2016
PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
Cancer immunology research
Severson JJ,Serracino HS,Mateescu V,Raeburn CD,McIntyre RC,Sams SB,Haugen BR,French JD
25-7029 was used in Flow cytometry/Cell sorting to determine that the release of PD-1 and Tim-3, and the inhibition of Tregs, may encourage tumour elimination in metastatic differentiated thyroid cancer.
Mon Jun 01 00:00:00 EDT 2015